QOA

N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]pyridine-4-carboxamide


Toggle HydrogenToggle Labels

Chemical Component Summary

NameN-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]pyridine-4-carboxamide
SynonymsPimasertib
Identifiers~{N}-[(2~{S})-2,3-bis(oxidanyl)propyl]-3-[(2-fluoranyl-4-iodanyl-phenyl)amino]pyridine-4-carboxamide
FormulaC15 H15 F I N3 O3
Molecular Weight431.201
TypeNON-POLYMER
Isomeric SMILESc1cc(c(cc1I)F)Nc2cnccc2C(=O)NC[C@@H](CO)O
InChIInChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1
InChIKeyVIUAUNHCRHHYNE-JTQLQIEISA-N

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count1
Bond Count39
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB14904 
NamePimasertib
Groups investigational
DescriptionPimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).
Synonyms
  • Pimasertib
  • N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide
  • Pimasertib hydrochloride
Categories
  • Nicotinic Acids
  • Protein Kinase Inhibitors
  • Pyridines
CAS number1236699-92-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Mitogen-activated protein kinase kinase (MAPKK)MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRL...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL2107832
PubChem 44187362
ChEMBL CHEMBL2107832
ChEBI CHEBI:94793